Mizuho Markets Americas LLC Has $6.06 Million Holdings in Colgate-Palmolive (NYSE:CL)

Mizuho Markets Americas LLC reduced its stake in Colgate-Palmolive (NYSE:CL - Free Report) by 16.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 58,385 shares of the company's stock after selling 11,756 shares during the period. Mizuho Markets Americas LLC's holdings in Colgate-Palmolive were worth $6,061,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also made changes to their positions in the company. E Fund Management Hong Kong Co. Ltd. bought a new stake in shares of Colgate-Palmolive in the second quarter valued at approximately $25,000. Continuum Advisory LLC raised its position in Colgate-Palmolive by 46.5% during the second quarter. Continuum Advisory LLC now owns 394 shares of the company's stock valued at $38,000 after purchasing an additional 125 shares in the last quarter. Reston Wealth Management LLC acquired a new position in Colgate-Palmolive during the third quarter valued at approximately $42,000. Capital Performance Advisors LLP acquired a new position in Colgate-Palmolive during the third quarter valued at approximately $53,000. Finally, Gradient Investments LLC raised its position in Colgate-Palmolive by 150.4% during the second quarter. Gradient Investments LLC now owns 666 shares of the company's stock valued at $65,000 after purchasing an additional 400 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Trading Up 2.3 %

CL traded up $2.11 during trading on Friday, reaching $93.56. 7,328,993 shares of the stock traded hands, compared to its average volume of 4,387,812. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The stock has a market capitalization of $76.44 billion, a PE ratio of 26.81, a P/E/G ratio of 3.25 and a beta of 0.42. The stock's 50-day moving average is $99.31 and its 200 day moving average is $98.45. Colgate-Palmolive has a 12 month low of $75.17 and a 12 month high of $109.30.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 2.14%. Colgate-Palmolive's dividend payout ratio (DPR) is currently 57.31%.

Insider Buying and Selling at Colgate-Palmolive

In other news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now owns 11,755 shares of the company's stock, valued at $1,220,874.30. This represents a 16.44 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.34% of the company's stock.

Wall Street Analyst Weigh In

CL has been the subject of several research analyst reports. Redburn Atlantic upgraded shares of Colgate-Palmolive to a "hold" rating in a research report on Thursday, August 1st. Deutsche Bank Aktiengesellschaft downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and boosted their price objective for the company from $107.00 to $109.00 in a research report on Monday, September 9th. JPMorgan Chase & Co. upped their price target on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an "overweight" rating in a report on Friday, October 11th. Hsbc Global Res downgraded shares of Colgate-Palmolive from a "strong-buy" rating to a "hold" rating in a report on Friday, July 26th. Finally, Piper Sandler initiated coverage on shares of Colgate-Palmolive in a report on Tuesday, September 24th. They set an "overweight" rating and a $121.00 price target for the company. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $105.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.